Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Oliceridine and its potential to revolutionize GI endoscopy sedation
Basavana Goudra,
Preet Singh
Division of Obstetrical Anesthesia
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oliceridine and its potential to revolutionize GI endoscopy sedation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Effect Profile
20%
Airway Management
20%
Analgesic Properties
20%
Anesthesia Provider
40%
Biased Receptor
20%
Commercial Success
20%
Computer-assisted Personalized Sedation
20%
Endoscopic Surgery
20%
Failure Rate
20%
Fentanyl
20%
Fospropofol
20%
G Protein
20%
Gastrointestinal
20%
Gastrointestinal Endoscopy
100%
Midazolam
20%
Morphine
20%
Oliceridine
100%
Opioids
20%
Prodrug
20%
Property Rate
20%
Propofol
100%
Receptor Agonist
20%
Remimazolam
40%
Respiratory Depression
20%
Screening Colonoscopy
20%
Sedasys
20%
Sedation
100%
Nursing and Health Professions
Adverse Event
16%
Airway Management
16%
Analgesic Agent
16%
Colonoscopy
16%
Duragesic
16%
Food and Drug Administration
16%
Fospropofol
16%
Gastrointestinal Endoscopy
100%
Guanine Nucleotide Binding Protein
16%
Infusion System
16%
Midazolam
16%
Morphine
16%
Oliceridine
100%
Prodrug
16%
Propofol
83%
Receptor
16%
Remimazolam
33%
Respiration Depression
66%
Sedation
100%
Medicine and Dentistry
Adverse Event
20%
Airway Management
20%
Colonoscopy
20%
Fentanyl
20%
Fospropofol
20%
Gastrointestinal Endoscopy
100%
Guanine Nucleotide Binding Protein
20%
Health Care Cost
20%
Midazolam
20%
Morphine
20%
Oliceridine
100%
Prodrug
20%
Propofol
100%
Receptor
20%
Remimazolam
40%
Respiration Depression
80%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
Analgesic Agent
20%
Duragesic
20%
Fospropofol
20%
Guanine Nucleotide Binding Protein
20%
Midazolam
20%
Morphine
20%
Oliceridine
100%
Prodrug
20%
Propofol
100%
Receptor Agonist
20%
Remimazolam
40%
Respiration Depression
80%